Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.

The Journal of the Korean Ophthalmological Society, with ISSN 0378-6471 and E-ISSN 2092-9374, is a pivotal resource in the field of ophthalmology, published by the esteemed Korean Ophthalmological Society. Based in South Korea, this journal is committed to advancing knowledge in ophthalmology through the dissemination of research that spans both clinical and experimental studies. Despite its current Q4 ranking in the 2023 Ophthalmology category, it serves as a crucial platform for emerging scholars, practitioners, and students seeking to contribute to and learn from the latest developments in eye care. While the journal does not currently offer open access, it is dedicated to fostering scientific dialogue and innovation within the community. With convergence years from 2018 to 2024, the journal's focus on contemporary issues in ophthalmology positions it as a relevant and timely source of information, critical for those engaged in this dynamic field. For further inquiries, the journal can be contacted at their address in Seoul, South Korea: SKY 1004 BLDG 701, 50-1 Jungnim-ro, Jung-gu, 04508.

Clinical Ophthalmology is a leading Open Access journal published by Dove Medical Press Ltd, dedicated to advancing the field of ophthalmology through peer-reviewed research and clinical studies. With a strong impact factor and ranked in the Q1 category of ophthalmology as of 2023, this journal is recognized for its significant contribution to the body of knowledge pertaining to eye health, vision science, and clinical practice. Its Scopus ranking places it within the top 30% of journals in the field, reflecting its influence and relevance in both academic and clinical landscapes. Since its inception in 2007, Clinical Ophthalmology has established a reputation for fostering high-quality research, providing a platform for researchers, professionals, and students to share their findings and insights. The journal's commitment to open access ensures that groundbreaking research is freely available to the global community, supporting innovation and collaboration in the pursuit of better patient outcomes worldwide. For those engaged in ophthalmological research and clinical practice, Clinical Ophthalmology serves as an invaluable resource and a hub for the latest developments in the field.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

The Journal of Optometry, published by Elsevier, is a leading open access journal dedicated to advancing the field of optometry and vision science. With an ISSN of 1888-4296 and an E-ISSN of 1989-1342, this journal serves as a pivotal platform for researchers, practitioners, and academics alike to disseminate and engage with high-quality original research and review articles. As of 2023, the journal holds an impressive Q2 ranking in the Optometry category, demonstrating its influence and relevance, particularly as it ranks #2 out of 12 in the Health Professions - Optometry category on Scopus with an 87th percentile. Since becoming open access in 2008, the Journal of Optometry has prioritized accessibility and the exchange of ideas, enriching the scholarly community and enhancing practical application in clinical settings. The journal welcomes submissions that push the boundaries of ocular research, clinical practices, and the education of optometry professionals, making it an essential resource for anyone invested in the future of eye health.

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

Ophthalmic Epidemiology, published by Taylor & Francis Inc, stands as a crucial platform in the fields of ophthalmology and epidemiology, with the journal's pivotal contributions recognized in its esteemed category quartiles, ranking Q1 in Ophthalmology and Q2 in Epidemiology for 2023. Since its inception in 1994, the journal has provided a multidisciplinary approach to understanding the distribution and determinants of ocular diseases, thereby informing public health practices and clinical interventions. With a commitment to disseminating high-impact research, it holds a Scopus rank of #45/137 in Ophthalmology and engages a global audience of researchers, practitioners, and students dedicated to advancing the field. Although it is not an open-access journal, Ophthalmic Epidemiology remains a vital resource for innovative studies and reviews that help shape evidence-based strategies to combat vision-related public health issues.